Pica, Roberta
 Distribuzione geografica
Continente #
EU - Europa 56
AS - Asia 42
NA - Nord America 15
SA - Sud America 10
Totale 123
Nazione #
IT - Italia 18
SG - Singapore 17
DE - Germania 13
US - Stati Uniti d'America 13
CN - Cina 12
BR - Brasile 9
FR - Francia 8
FI - Finlandia 6
KR - Corea 5
ES - Italia 3
ID - Indonesia 3
AT - Austria 2
CA - Canada 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
EC - Ecuador 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
PL - Polonia 1
TR - Turchia 1
Totale 123
Città #
Singapore 14
Frankfurt am Main 9
Helsinki 6
Rome 5
Seoul 5
Appignano 4
Hefei 4
Munich 4
Jakarta 3
Madrid 3
Florence 2
Los Angeles 2
Paris 2
Abu Dhabi 1
Baghdad 1
Betim 1
Boardman 1
Brooklyn 1
Cleveland 1
Floriano 1
Fullerton 1
Istanbul 1
Joinville 1
Milan 1
Montreal 1
Moscow 1
Nagoya 1
Nova Friburgo 1
Ottawa 1
Pederneiras 1
Phoenix 1
Porto Alegre 1
Quito 1
São Bernardo do Campo 1
São Sebastião do Paraíso 1
Tirana 1
Vienna 1
Warsaw 1
Totale 88
Nome #
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 41
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 36
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 32
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 18
Totale 127
Categoria #
all - tutte 643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 643


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202421 0 0 0 0 0 0 0 0 7 8 3 3
2024/2025106 0 2 8 7 7 4 10 2 6 12 30 18
Totale 127